Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goserelin for Ovarian Protection in Breast Cancer
NCT02518191Phase 3Completed
- Start
- Sep 2015
- Primary completion
- Jan 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of goserelin in premature ovarian insufficiency (POI). Started Sep 2015; status: completed.
02
Drugs
goserelin
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT02518191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02518191.